Back
Monopar Therapeutics Stock Predictions

Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
MNPR
Monopar Therapeutics
Last Price:
$43.08
Seasonality Move:
-18.4%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Monopar Therapeutics Stock Forecast
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 558.6% based on the past 5 years of stock performance.
-
Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Monopar Therapeutics Stock Undervalued?The current Monopar Therapeutics [MNPR] share price is $43.10. The Score for MNPR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Monopar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 558.6% based on the past 5 years of stock performance.
Monopar Therapeutics Stock Rating
Buy
62
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics overpriced?
-
Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Monopar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com
52-Week Data
52-Week High:
54.30
52-Week Low:
1.70
Prediction Charts
Market Cap:
227.5M
Price in USD:
43.10
Volume:
57.5K
Beta:
1.33
Technical Analysis
SMA50:
31.85
SMA100:
22.12
SMA200:
12.72
52-Wk Change:
2454.83%
Stock Predictions
-
Is Monopar Therapeutics stock public?Yes, Monopar Therapeutics is a publicly traded company.
-
What is the Monopar Therapeutics stock quote today?The Monopar Therapeutics stock price is 43.10 USD today.
-
How to buy Monopar Therapeutics stock online?You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-28 | 34.80 | 41.82 | 42.39 | 34.50 |
Jan-29 | 42.02 | 38.80 | 42.02 | 34.41 |
Jan-30 | 39.50 | 42.50 | 42.50 | 37.20 |
Jan-31 | 42.93 | 43.94 | 44.86 | 38.90 |
Feb-3 | 41.45 | 43.55 | 44.36 | 38.90 |
Feb-4 | 43.50 | 48.00 | 49.98 | 41.83 |
Feb-5 | 48.93 | 48.77 | 51.48 | 45.95 |
Feb-6 | 48.81 | 47.11 | 51.22 | 43.44 |
Feb-7 | 46.16 | 48.46 | 49.22 | 46.16 |
Feb-10 | 48.50 | 51.89 | 54.30 | 47.81 |
Feb-11 | 52.12 | 51.33 | 52.25 | 48.43 |
Feb-12 | 51.21 | 50.52 | 51.80 | 49.05 |
Feb-13 | 50.38 | 44.68 | 50.38 | 43.97 |
Feb-14 | 43.00 | 43.10 | 43.60 | 39.72 |
Monopar Therapeutics Earnings
Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monopar Therapeutics Forecast Revenue Growth
Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.